Aida Pharmaceuticals, Inc. (AIDA)
OTCMKTS · Delayed Price · Currency is USD
0.0003
+0.0001 (50.00%)
At close: Dec 30, 2025

Aida Pharmaceuticals Company Description

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China.

It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment.

The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers.

Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.

Aida Pharmaceuticals, Inc.
Country United States
Founded 1999
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 450
CEO Biao Jin

Contact Details

Address:
31 Dingjiang Road
Hangzhou, Nevada 310016
China
Phone 86 571 8580 2712

Stock Details

Ticker Symbol AIDA
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US0087211027
SIC Code 2834

Key Executives

Name Position
Biao Jin Chairman and Chief Executive Officer
Lin Hui Chief Financial Officer and Principal Accounting Officer
Yue Jun Jiang Chief of Investment Department and Secretary
Qiu Jiajun Member of Compensation Committee and Director